Trump administration’s view on medication-assisted treatment has evolved from critical to fully supportive. Tom Price, Mr. Trump’s first Health and Human Services secretary, appalled many addiction expertsby saying, “If we’re just substituting one opioid for another, we’re not moving the dial much.” But Mr. Price’s successor, Alex Azar, a former pharmaceutical executive, has embraced the approach.
How extremely shocking that a pharma guy would want to enrich the industry.
When the administration announced $1 billion in new grants to expand access to treatment earlier this year, it emphasizedthat only programs that made these medicines available were eligible.
This is a real issue that a Democratic nominee could embrace next year. Instead of criticizing Trump’s correct instincts on Syria and the wall, criticize this clearly pig-headed policy.
Of course, talking about opioids without endorsing the wall is an exercise in hypocrisy but it’s not like we are not used to that.